EcoR1 Capital Fund, L.P.
Director

EcoR1 Capital Fund, L.P. insider trades: Nuvation Bio (NUVB) stock buys and sales

Director, Nuvation Bio Last trade Feb 21, 2023 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2014
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where EcoR1 Capital Fund, L.P. reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 21, 2023NUVB↑ Buy$6.7M
Nov 24, 2021NUVB↑ Buy$3.3M
Nov 24, 2021NUVB↑ Buy$167K
Jul 31, 2021NUVB↓ Sell$2.1M
Apr 13, 2021NUVB↑ Buy$4.0M
Apr 13, 2021NUVB↑ Buy$578K
Apr 9, 2021PANA↑ Buy$5.5M
Jul 6, 2020PANA↑ Buy$3.9M
May 27, 2014GNVC↑ Buy$28K
May 27, 2014GNVC↑ Buy$26K
Mar 28, 2014GNVC↑ Buy$187K
Mar 28, 2014GNVC↑ Buy$125K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NUVB insiders

Open-market trades in the last 12 months

About EcoR1 Capital Fund, L.P.'s insider trades

EcoR1 Capital Fund, L.P. is a director at Nuvation Bio (NUVB). Since Mar 28, 2014, it has reported 11 open-market purchases worth $24.5M and 1 sale worth $2.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include shares returned to the company (1 filing), grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.